Defunct Company
Total Trials
8
As Lead Sponsor
1
As Collaborator
7
Total Enrollment
1,558
NCT01087008
Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse
Phase: Phase 4
Role: Collaborator
Start: Apr 30, 2010
Completion: Jun 5, 2013
NCT01717105
Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients
Phase: N/A
Start: Mar 31, 2011
Completion: Feb 28, 2013
NCT01802450
Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
Phase: Phase 2
Start: Mar 31, 2013
Completion: Dec 31, 2016
NCT02319135
Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase: Phase 3
Start: Oct 31, 2014
Completion: Oct 28, 2019
NCT02889510
Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
Start: Oct 4, 2016
Completion: Dec 16, 2019
NCT04366908
Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
Start: May 7, 2020
Completion: Apr 19, 2022
NCT04271839
Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients
Start: Jun 11, 2020
Completion: May 31, 2021
NCT05487365
Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF
Role: Lead Sponsor
Start: May 21, 2022
Completion: Nov 21, 2022